Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748565 · ClinicalTrials.gov registry record
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 260
- Enrollment target
NCT01748565 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 260 participants.
The verdict
NCT01748565 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
The purpose of this study is to identify biological markers that might predict premature infants who are at a higher risk for developing BPD, and to correlate the presence of these markers with infant symptoms and lung function in the first year after discharge from the hospital.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01748565
The ClinicalTrials.gov registry entry for NCT01748565 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01748565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01748565 about?
NCT01748565 is a clinical study titled "Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia". The purpose of this study is to identify biological markers that might predict premature infants who are at a higher risk for developing BPD, and to correlate the presence of these markers with infant symptoms and lung function in the first year after discharge from the hospital.
What is the current status of trial NCT01748565?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2012-05. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01748565?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.